🇺🇸 Cefazoline in United States

357 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Anaphylactic Shock — 85 reports (23.81%)
  2. Hypotension — 62 reports (17.37%)
  3. Acute Kidney Injury — 39 reports (10.92%)
  4. Acute Generalised Exanthematous Pustulosis — 26 reports (7.28%)
  5. Rash — 26 reports (7.28%)
  6. Urticaria — 26 reports (7.28%)
  7. Tachycardia — 24 reports (6.72%)
  8. Thrombocytopenia — 24 reports (6.72%)
  9. Pruritus — 23 reports (6.44%)
  10. Anaemia — 22 reports (6.16%)

Source database →

Other Infectious Disease approved in United States

Frequently asked questions

Is Cefazoline approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Cefazoline in United States?

Nantes University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.